Epidemiology of Lupus Nephritis in Nephrology Unit in Assiut University Hospital

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT05120882

Recruitment Status : Not yet recruiting

First Posted : November 15, 2021

Last Update Posted : November 15, 2021

See Contacts and Locations

Sponsor:

Information provided by (Responsible Party):

Ekram Farouk Ibrahim, Assiut University

Tracking Information

First Submitted Date

October 30, 2021

First Posted Date

November 15, 2021

Last Update Posted Date

November 15, 2021

Estimated Study Start Date

December 2021

Estimated Primary Completion Date

May 2022 (Final data collection date for primary outcome measure)

Current Primary Outcome Measures

Study of epidemiology of lupus nephritis patients [ Time Frame: 6 months ]

Detection of different risk factors such as socioeconomic status and its relation to lupus nephritis To study the outcome of treatment plans in different classes of lupus nephritis

Original Primary Outcome Measures

Same as current

Change History

No Changes Posted

Current Secondary Outcome Measures

Not Provided

Original Secondary Outcome Measures

Not Provided

Current Other Pre-specified Outcome Measures

Not Provided

Original Other Pre-specified Outcome Measures

Not Provided

Descriptive Information

Brief Title

Epidemiology of Lupus Nephritis in Nephrology Unit in Assiut University Hospital

Official Title

Epidemiology of Lupus Nephritis in Nephrology Unit in Assiut University Hospital

Brief Summary

study epidemiology of lupus nephritis patients admitted to nephrology unit inward or in outpatient clinic in Assiut Nephrology Unit

Detailed Description

this study are:

To describe socio-demographic characteristics of lupus nephritis patients in Nephrology Unit of Assiut University hospital ( Old and New cases).

To determine the associated risk factors in the study population

To describe the clinical, laboratory characteristics, treatment modalities of lupus nephritis patients in Nephrology Unit of Assiut University hospital ( Old and New cases)

To Identify outcomes of treatment of these cases within 2 years according to different classes

To evaluate the effectiveness of (type of interventions mentioned) among those patients.

Study Type

Observational

Study Design

Observational Model: Cohort
Time Perspective: Cross-Sectional

Target Follow-Up Duration

Not Provided

Biospecimen

Not Provided

Sampling Method

Probability Sample

Study Population

All patients admitted to nephrology unit or visiting the outpatient nephrology clinic, previously or newly diagnosed with lupus nephritis in Internal Medicine Department in assiut University hospital will be recruited from December 2021 till May 2022.

Condition

Lupus Nephritis

Intervention

Not Provided

Study Groups/Cohorts

Not Provided

Publications *

Not Provided

* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.

Recruitment Information

Recruitment Status

Not yet recruiting

Estimated Enrollment

Original Estimated Enrollment

Same as current

Estimated Study Completion Date

June 2022

Estimated Primary Completion Date

May 2022 (Final data collection date for primary outcome measure)

Eligibility Criteria

Inclusion Criteria:

all patients admitted to nephrology unit or visiting the outpatient nephrology clinic,previously or newly diagnosed with lupus nephritis.

Exclusion Criteria:

incomplete Criteria for diagnosis of systemic lupus or presence of associated renal disease.

Sex/Gender

Sexes Eligible for Study:

All

Ages

18 Years to 70 Years (Adult, Older Adult)

Accepts Healthy Volunteers

Not Provided

Contacts

Listed Location Countries

Not Provided

Removed Location Countries

Administrative Information

NCT Number

NCT05120882

Other Study ID Numbers

lupus nephritis

Has Data Monitoring Committee

Not Provided

U.S. FDA-regulated Product

Studies a U.S. FDA-regulated Drug Product:	No
Studies a U.S. FDA-regulated Device Product:	No

IPD Sharing Statement

Not Provided

Responsible Party

Ekram Farouk Ibrahim, Assiut University

Study Sponsor

Assiut University

Collaborators

Not Provided

Investigators

Not Provided

PRS Account

Assiut University

Verification Date

October 2021

To Top